Avoiding Radiation Toxicity: Understanding Dosimetric Endpoints and Challenges in Radiopharmaceutical Clinical Trials
XTalks
FEBRUARY 13, 2023
Radiopharmaceutical therapy (RPT) uses isotopes that are conjugated to tumor-targeting agents (such as peptides, antibodies and novel small molecules). Radionuclide-ligand conjugates, including radionuclides that are conjugated to antibodies or peptides, have been studied extensively.
52 
Let's personalize your content